New advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor-stimulating agents
Ara Metjian1, Charles S Abrams21Department of Medicine, Duke University Medical Center, Durham, NC, USA; 2Department of Medicine, University of Pennsylvania, Philadelphia, PA, USAAbstract: Decades of basic science and clinical research have led to an increased understanding of the pathophysiology of...
Saved in:
Main Authors: | Ara Metjian, Charles S Abrams |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2009
|
Subjects: | |
Online Access: | https://doaj.org/article/74cf4975d3a343f5966897488f73a8f1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THE OUTCOME OF IMMUNE THROMBOCYTOPENIC PURPURA IN CHILDHOOD AND THE RISK FACTORS FOR CHRONICITY
by: Barış YILMAZ, et al.
Published: (2021) -
Treatment of immune thrombocytopenic purpura: focus on eltrombopag
by: Lawrence Rice
Published: (2009) -
Emerging Concepts in Immune Thrombotic Thrombocytopenic Purpura
by: Aicha Laghmouchi, et al.
Published: (2021) -
Management of chronic immune thrombocytopenic purpura: targeting insufficient megakaryopoiesis as a novel therapeutic principle
by: Andreas Rank, et al.
Published: (2010) -
THROMBOTIC THROMBOCYTOPENIC PURPURA: OUR CLINICAL EXPERIENCE
by: Zahid Farooq Baig, et al.
Published: (2018)